「concentration」の検索結果

Deep analysis of Amazon niche markets by keyword, covering monopoly level, brand concentration, new product success rate, and market opportunity score. Trigger when the user mentions niche market analysis, keyword market research, monopoly assessment, brand concentration analysis, new product success rate, market demand score, competitive landscape, Amazon sub-market exploration, niche market analysis, keyword market, monopoly level, brand concentration, new product success rate, market opportunity score, competitive landscape, Nexscope data. Even if the user does not explicitly mention "niche market", if their need involves evaluating the competitive landscape, brand density, or opportunity potential of the Amazon market at the keyword dimension level, this skill should also be triggered.

日本語の概要は準備中です。原文の説明を表示しています。

Deep analysis of Amazon niche markets by product ASIN, covering monopoly level, brand concentration, new product success rate, and market opportunity score. Trigger when the user mentions niche market analysis by ASIN, ASIN market research, ASIN niche lookup, monopoly assessment, brand concentration analysis, new product success rate, market demand score, competitive landscape, Amazon sub-market exploration, ASIN niche analysis, niche by ASIN, monopoly level, brand concentration, new product success rate, market opportunity score, competitive landscape, Nexscope data. Even if the user does not explicitly mention "niche market" or "ASIN", if their need involves evaluating the competitive landscape, brand density, or opportunity potential of the niche segment a specific product ASIN belongs to, this skill should also be triggered.

日本語の概要は準備中です。原文の説明を表示しています。

Monitors LP base composition with concentration analysis, redemption risk, and re-up probability assessment. Use when analyzing investor concentration, assessing re-up risk, or managing LP base diversification.

日本語の概要は準備中です。原文の説明を表示しています。

Turn in vitro potency and animal pharmacokinetics into a defensible human dose projection — the arithmetic that decides whether a compound can reach its target concentration safely. Use this skill for non-compartmental analysis of a concentration-time profile (AUC, Cmax, terminal half-life, clearance, volume of distribution), one- and two-compartment simulation of a dosing regimen, interspecies allometric scaling, human-equivalent dose conversion by body surface area, and the exposure margin between a projected therapeutic concentration and a toxicology no-effect level. Also trigger on non-compartmental analysis, AUC, clearance, volume of distribution, allometric scaling, human equivalent dose, first-in-human, NOAEL, therapeutic index, or exposure margin.

日本語の概要は準備中です。原文の説明を表示しています。

Dose-response / concentration-response curve fitting — IC50, EC50, Hill slope, Emax/Emin efficacy, and relative potency from paired concentration vs response data (enzyme/cell assays, drug screening, agonist/antagonist pharmacology). Fits the 4-parameter logistic (Hill sigmoidal) model. Use when you have concentrations + responses and need a potency value, to compare two compounds' potency, or to judge curve quality. NOT for image-derived dose-response (use tooluniverse-image-analysis) and NOT for survival/regression (use tooluniverse-statistical-modeling).

日本語の概要は準備中です。原文の説明を表示しています。

Pharmacokinetic and pharmacodynamic modelling and simulation - non-compartmental analysis, compartmental and population PK, PK/PD and exposure-response, TMDD, PBPK orientation, bioequivalence, allometric scaling and first-in-human dose, drug interaction prediction, and Bayesian therapeutic drug monitoring. Use when analysing concentration-time data, deriving exposure metrics, fitting PK or PD models, or evaluating dosing regimens. Triggers include "pharmacokinetics", "pharmacodynamics", "PK/PD", "NCA", "non-compartmental", "AUC", "Cmax", "lambda z", "half-life", "clearance", "volume of distribution", "compartmental model", "population PK", "popPK", "NONMEM", "nlmixr2", "Pharmpy", "Monolix", "exposure-response", "Emax", "EC50", "indirect response", "effect compartment", "TMDD", "PBPK", "bioequivalence", "RSABE", "ABEL", "allometric scaling", "first-in-human", "MABEL", "drug-drug interaction", "DDI", "ICH M12", "concentration-QTc", "therapeutic drug monitoring", "MIPD", and "dosing regimen".

日本語の概要は準備中です。原文の説明を表示しています。

Detect structural macro regime transitions (1-2 year horizon) using cross-asset ratio analysis. Analyze RSP/SPY concentration, yield curve, credit conditions, size factor, equity-bond relationship, and sector rotation to identify regime shifts between Concentration, Broadening, Contraction, Inflationary, and Transitional states. Run when user asks about macro regime, market regime change, structural rotation, or long-term market positioning.

日本語の概要は準備中です。原文の説明を表示しています。

Supply chain mapping, supplier dependency analysis, customer concentration, geographic concentration, bottleneck identification, supply chain risk, logistics network, sourcing strategy, inventory management, vertical integration analysis

日本語の概要は準備中です。原文の説明を表示しています。

Prepare a meeting-ready alternative-investments brief for a client, household, IRA, trust, or named account before a review — pulls the alts book from iCapital or Addepar (positions, NAV vs. commitment, called and unfunded amounts, contributions/distributions/subscriptions/redemptions, lockups, and the platform's own IRR/TVPI/DPI/RVPI) and sits it beside the liquid book and IPS target from the connected portfolio system (Orion Connect, Addepar, or Envestnet), then flags cash needed for capital calls, alts % vs. target, concentration, unfunded concentration, and stale as-of data. Cites the source platform on every figure and keeps disclosures on the page. Does not recommend funds, forecast NAVs/IRRs, or simulate allocation changes. Triggers on "alts brief", "/alts-brief", "prep the [client]'s alts review", "what's going on with [client]'s PE/private investments", "how's [client] doing on their alts", or any request to review a household's alternative investment positions before a meeting.

日本語の概要は準備中です。原文の説明を表示しています。

Use Nexscope data to reverse-lookup traffic keywords for any Amazon ASIN, including organic ranking, ad ranking, search volume, traffic share, organic/paid scores, ABA TOP3 click concentration, click conversion rate, year-over-year search volume changes, and weekly/monthly time windows. Trigger when the user mentions ASIN keyword analysis, ASIN reverse lookup, traffic keyword research, organic ranking query, ad ranking query, keyword position tracking, Nexscope keyword data, competitor keyword peeking, viewing which keywords drive traffic to a product, analyzing keyword performance for a specific ASIN, time windows by week/month/recent N days, ASIN reverse keyword lookup, traffic keywords, organic ranking, ad ranking, search volume, Nexscope keywords, competitor keyword reverse lookup, click concentration, click-to-purchase conversion, week-over-week search volume. Even if the user does not explicitly mention "Nexscope", if their need involves finding keywords associated with a specific Amazon product (ASIN), this skill should also be triggered.

日本語の概要は準備中です。原文の説明を表示しています。

Use Nexscope market list capability to filter Amazon niche markets by category dimensions, supporting market size, competition, top concentration, seller structure, new product share, price/rating/margin ranges, and many other criteria for discovering viable markets and evaluating product selection directions. Trigger when the user mentions Amazon market research, niche category research, market opportunity screening, market concentration analysis, new product opportunities, market selection, Nexscope market research, category market research. Even if the user does not explicitly mention "Nexscope", if the need is to screen and evaluate Amazon markets by category dimensions, this skill should also be triggered.

日本語の概要は準備中です。原文の説明を表示しています。

Interprets the aldosterone-to-renin ratio using active renin concentration (ARC) to screen for primary aldosteronism. Triggered when a clinician has PAC and ARC results and asks 'How do I interpret this ARR using active renin concentration?'

日本語の概要は準備中です。原文の説明を表示しています。

Pharmacokinetic (PK) analysis of concentration-time data — non-compartmental analysis (NCA) for Cmax, Tmax, AUC (0-t and 0-∞), terminal half-life, clearance (CL), volume of distribution (Vd), MRT, and absolute bioavailability (F). Also one-compartment fitting. Use when you have plasma/serum drug concentrations over time after a dose and need PK parameters, or to compute bioavailability from IV + oral AUCs. NOT for ADMET property prediction from structure (use tooluniverse-admet-prediction).

日本語の概要は準備中です。原文の説明を表示しています。

Designs and validates quantitative targeted metabolomics assays (MRM/SRM on triple-quadrupole, PRM on high-resolution instruments) to report absolute concentrations. Covers the internal-standard strategy (external cal -> global IS -> standard addition -> stable-isotope-labeled IS), weighted calibration judged by back-calculated %RE not R-squared, ion-ratio quantifier/qualifier confirmation, matrix-effect/recovery characterization, and ICH M10 method validation. Use when quantifying a closed panel of known metabolites with units, building or validating an LC-MS/MS assay, choosing an IS or calibration weighting, or judging whether a reported concentration is trustworthy. For untargeted feature detection see metabolomics/xcms-preprocessing; for group statistics see metabolomics/statistical-analysis; for flux/MID/tracing see metabolomics/isotope-tracing.

日本語の概要は準備中です。原文の説明を表示しています。

Build EcoSIM atmospheric greenhouse-gas forcing files by combining a historical monthly atmgas NetCDF with RCMIP/CMIP6 SSP concentration pathways. Use when Codex needs SSP245/SSP585 or other SSP atmospheric CO2, CH4, and N2O concentrations, key-year tables, or scenario NetCDF files spanning historical years through 2100 for EcoSIM or related biogeochemical forcing workflows.

日本語の概要は準備中です。原文の説明を表示しています。

Simulates biochemical kinetic models from SBML or Antimony with Tellurium and libRoadRunner, checks model units, compares deterministic parameter perturbations, and exports and replays SBML plus SED-ML COMBINE archives. Use for reaction-network time courses, kinetic parameters, concentration dynamics and reproducible simulation experiments; steady-state constraint-based metabolic flux analysis belongs to cobrapy.

日本語の概要は準備中です。原文の説明を表示しています。

Liquidation level analysis and heatmap interpretation — identify leveraged position concentration, liquidation cascades, stop-hunt zones, and use liquidation data as support/resistance signals.

日本語の概要は準備中です。原文の説明を表示しています。

Audits a project's dependencies for supply-chain risk: version-matched advisories for direct dependencies and the full lockfile tree, abandoned or archived upstreams, npm publisher concentration, and install-time script execution. Use when asked to audit dependencies, assess supply-chain or third-party package risk, or review a dependency tree before an engagement.

日本語の概要は準備中です。原文の説明を表示しています。

Query the OFR (Office of Financial Research) Hedge Fund Monitor API for hedge fund data including SEC Form PF aggregated statistics, CFTC Traders in Financial Futures, FICC Sponsored Repo volumes, and FRB SCOOS dealer financing terms. Access time series data on hedge fund size, leverage, counterparties, liquidity, complexity, and risk management. No API key or registration required. Use when working with hedge fund data, systemic risk monitoring, financial stability research, hedge fund leverage or leverage ratios, counterparty concentration, Form PF statistics, repo market data, or OFR financial research data.

日本語の概要は準備中です。原文の説明を表示しています。

Calculate risk-based position sizes for long stock trades. Use when user asks about position sizing, how many shares to buy, risk per trade, Kelly criterion, ATR-based sizing, fractional-share sizing, or portfolio risk allocation. Supports stop-loss distance calculation, volatility scaling, and sector concentration checks.

日本語の概要は準備中です。原文の説明を表示しています。

Manages the flow of goods and inputs — sourcing, inventory, lead times, fulfillment, and supply risk. Use this to reduce stockouts or excess inventory, plan for a supplier failure, decide reorder points and safety stock, improve fulfillment reliability, or assess concentration risk in a supply base.

日本語の概要は準備中です。原文の説明を表示しています。

Selects, contracts, and manages suppliers and vendors — requirements, evaluation, negotiation support, onboarding, performance management, and exit. Use this to choose a vendor, run a selection process, structure a service agreement's operational terms, manage an underperforming supplier, plan an exit or migration, or assess concentration and continuity risk.

日本語の概要は準備中です。原文の説明を表示しています。

Manages cash and liquidity — cash forecasting, runway, working capital, banking structure, and currency and counterparty exposure. Use this to build a cash forecast, extend runway, improve working capital, decide where cash should sit, or assess exposure to a bank, currency, or customer concentration.

日本語の概要は準備中です。原文の説明を表示しています。

Simulate the acquirer's diligence team hunting for reasons to cut your price — their internal red-flags memo with a price-chip estimate per finding. Use when asked to red-team my company before a sale, how will an acquirer attack our valuation, pre-diligence audit, or what will DD find. Produces the acquirer's internal memo (revenue quality, key-person, tech debt, concentration, legal) and a debrief on which flags are fixable before a process.

日本語の概要は準備中です。原文の説明を表示しています。